Table 1 Characteristics of patients assessed
Median (range) | Overall (n = 203) | Patients with BPH or GGG 1–2 prostate cancer | Patients with GGG 3–5 prostate cancer | p-value |
|---|---|---|---|---|
(n = 178, 87.7%) | (n = 25, 12.3%) | |||
Median age (range), years | 68 (47–81) | 67 (47–81) | 72 (53–80) | 0.004 |
Median PSA (range), ng/mL | 5.5 (1.5–9.9) | 5.5 (1.5–9.9) | 6.4 (2.7–9.6) | 0.027 |
Median DHEA (range), pg/mL | 1654.7 (419.4–8989.3) | 1704.3 (419.4–8989.3) | 1334.6 (457.4–3563.4) | 0.040 |
Median prostate volume (range), mL | 31.2 (8.4–102.3) | 31.4 (8.4–102.3) | 25.3 (11.5–58.0) | 0.035 |